Newswise — May 21, 2020 – How should orthopaedic surgeons respond to the COVID-19 pandemic? A review in The Journal of Bone & Joint Surgery analyzes evidence and strategies for managing the novel SARS-CoV-2 virus – including critical lessons from past pandemics. The journal is published in the Lippincott portfolio by Wolters Kluwer.
“Controlling the spread of COVID-19 has become the singular focus on several countries, with unprecedented international collaboration and rapid dissemination of emerging scientific evidence,” according to the rapid evidence review by Mohit Bhandari, MD, PhD, FRCSC, and colleagues of McMaster University, Hamilton, Ont., Canada. In a comprehensive review, they identify and analyze available evidence on the COVID-19 pandemic.
COVID-19 – Emerging Evidence and Evolving Strategies
Although the global spread and societal impact of SARS-CoV-2 may seem unprecedented, it is the third major outbreak of coronavirus infection to occur in less than 20 years – following severe acute respiratory syndrome (SARS) in 2002-03 and Middle East Respiratory Syndrome (MERS) in 2012.
Symptoms of COVID-19 – most commonly fever and cough – appear an average of five days after infection and almost always within 11.5 days. Evidence suggests that about 20 percent of cases are severe or critical, while about 88 percent have abnormal findings on chest CT scans. Estimates of mortality vary but may approach four percent in confirmed cases of COVID-19. Older patients and those with comorbid conditions, such as cardiovascular disease and diabetes, are at higher risk of death.
There is currently no specific treatment for COVID-19. Trials are underway to evaluate antivirals and other potentially beneficial medications; some of these treatments “may be trialed if available in severe cases.” The race is on to develop an effective vaccine against SARS-CoV-2, with several potential targets being evaluated. However, as the authors write, “[A] vaccine that is ready for widespread use is likely still months, possibly years, away.”
In the meantime, hygiene, social distancing, and isolation measures are needed to curb virus transmission. Experience suggests that these measures have been effective in “flattening the curve” of viral transmission – as demonstrated by the textbook example of the 1918 influenza pandemic. In that historic epidemic as in the SARS pandemic, a second wave of infections occurred after relaxation of containment measures.
“It is essential that we continue these practices, as the outbreak is currently expected to last for many more months and we must be mindful of the lessons learned from past pandemics to prevent a second wave from occurring,” according to Dr. Bhandari and colleagues. That’s especially important in limiting the spread of SARS-Cov-2 by asymptomatic and pre-symptomatic individuals.
Guiding Surgeons Through the Pandemic
The authors summarize recent guidance to surgeons and other frontline healthcare professionals, including postponing or cancelling elective or nonemergency surgical procedures; shifting inpatient tests or procedures to outpatient settings, if possible; and taking steps to conserve available resources and healthcare capacity. The review includes recommended steps for necessary surgery in patients with COVID-19.
Dr. Bhandari is Editor-in-Chief of OrthoEvidence, a global online source for high quality and timely orthopedic-only, evidence-based summaries. In partnership with JBJS, OrthoEvidence has created a COVID-19 Resource Center, offering podcasts, original content, links to critical breaking studies, and global perspectives on COVID-19 from orthopaedic surgeons around the world on how they’re responding to the pandemic.
“Data is the differentiator in this global crisis,” Dr. Bhandari writes in a message to the OrthoEvidence community. “We are proud to stand with our community to provide as much evidence as we can to help you all make important decisions for your communities and your patients.”
About The Journal of Bone & Joint Surgery
The Journal of Bone & Joint Surgery (JBJS) has been the most valued source of information for orthopaedic surgeons and researchers for over 125 years and is the gold standard in peer-reviewed scientific information in the field. A core journal and essential reading for general as well as specialist orthopaedic surgeons worldwide, The Journal publishes evidence-based research to enhance the quality of care for orthopaedic patients. Standards of excellence and high quality are maintained in everything we do, from the science of the content published to the customer service we provide. JBJS is an independent, non-profit journal.
About Wolters Kluwer
Wolters Kluwer (WKL) is a global leader in professional information, software solutions, and services for the clinicians, nurses, accountants, lawyers, and tax, finance, audit, risk, compliance, and regulatory sectors. We help our customers make critical decisions every day by providing expert solutions that combine deep domain knowledge with advanced technology and services.
Wolters Kluwer reported 2019 annual revenues of €4.6 billion. The group serves customers in over 180 countries, maintains operations in over 40 countries, and employs approximately 19,000 people worldwide. The company is headquartered in Alphen aan den Rijn, the Netherlands.
Wolters Kluwer provides trusted clinical technology and evidence-based solutions that engage clinicians, patients, researchers and students with advanced clinical decision support, learning and research and clinical intelligence. For more information about our solutions, visit http://healthclarity.wolterskluwer.com and follow us on LinkedIn and Twitter @WKHealth.